









Markets
/
Stocks
/
nasdaq-biib
/

Biogen Inc

BIIB

View Detailed Chart

137.145USD

-2.165-1.55%

Market hours （ET）Quotes delayed by 15 min

20.11BMarket Cap

13.59P/E TTM



Biogen Inc

137.145

-2.165-1.55%

Overview Company Financials

Financials

Intraday

30m

Today

-1.55%

5 Days

-1.05%

1 Month

+3.44%

6 Months

-2.92%

Year to Date

-10.32%

1 Year

-33.10%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 36 analysts

BUY

Current Rating

168.489

Target Price

20.95%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

178

Total

Median

Average

Company name

Ratings

Analysts

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Eli Lilly and Co

LLY

AbbVie Inc

ABBV

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(3)

Neutral(1)

Buy(6)

Indicators

Sell(1)

Neutral(1)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

1.764

Buy

RSI(14)

62.125

Neutral

STOCH(KDJ)(9,3,3)

81.069

Overbought

ATR(14)

3.894

High Vlolatility

CCI(14)

104.318

Buy

Williams %R

19.648

Overbought

TRIX(12,20)

0.251

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

138.438

Sell

MA10

135.785

Buy

MA20

132.724

Buy

MA50

130.745

Buy

MA100

127.314

Buy

MA200

138.284

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).

Ticker SymbolBIIB

CompanyBiogen Inc

CEOMr. Christopher A. (Chris) Viehbacher

Websitehttps://www.biogen.com/